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Abstract
Genome-wide identification of mRNAs regulated by RNA-binding proteins is crucial to uncover post-transcriptional gene
regulatory systems. The conserved PUF family RNA-binding proteins repress gene expression post-transcriptionally by
binding to sequence elements in 39-UTRs of mRNAs. Despite their well-studied implications for development and
neurogenesis in metazoa, the mammalian PUF family members are only poorly characterized and mRNA targets are largely
unknown. We have systematically identified the mRNAs associated with the two human PUF proteins, PUM1 and PUM2, by
the recovery of endogenously formed ribonucleoprotein complexes and the analysis of associated RNAs with DNA
microarrays. A largely overlapping set comprised of hundreds of mRNAs were reproducibly associated with the paralogous
PUM proteins, many of them encoding functionally related proteins. A characteristic PUF-binding motif was highly enriched
among PUM bound messages and validated with RNA pull-down experiments. Moreover, PUF motifs as well as surrounding
sequences exhibit higher conservation in PUM bound messages as opposed to transcripts that were not found to be
associated, suggesting that PUM function may be modulated by other factors that bind conserved elements. Strikingly, we
found that PUF motifs are enriched around predicted miRNA binding sites and that high-confidence miRNA binding sites
are significantly enriched in the 39-UTRs of experimentally determined PUM1 and PUM2 targets, strongly suggesting an
interaction of human PUM proteins with the miRNA regulatory system. Our work suggests extensive connections between
the RBP and miRNA post-transcriptional regulatory systems and provides a framework for deciphering the molecular
mechanism by which PUF proteins regulate their target mRNAs.
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Introduction
Gene expression is regulated at multiple levels to ensure
coordinated synthesis of the cells’ macromolecular components.
Besides transcriptional regulation, it is becoming increasingly
recognized that control of the post-transcriptional steps has
substantial impact on gene expression with widespread physiolog-
ical implications [1,2]. This regulation is mediated by hundreds of
RNA-binding proteins (RBPs) that are encoded in eukaryotic
genomes and bind to sequence/structural elements in mRNAs, and
thereby regulate the localization, translation or decay of messages
[3–7]. On the other hand, microRNAs (miRNAs), ,22 nucleotide
(nt) long RNA molecules, can repress gene expression by base-
pairing with sequences in 39-untranslated regions (39-UTRs) of
messages and thus inhibit their translation or promote decay [8,9].
The PUmilio-Fem-3-binding factor (PUF) proteins comprise an
evolutionarily conserved family of RNA-binding proteins that are
implicated in various physiological processes [10,11]. They are
definedbythepresenceofanRNA-bindingdomain,termedPumilio-
homology domain (Pum-HD), which consists of eight repeats, each of
which makes contact with a different RNA base [12–15]. PUF
proteins bind to an RNA element that comprises a core ‘UGUR’
tetranucleotide followed by 39-UTR sequences that vary among PUF
proteins. In concert with other factors, PUFs repress gene expression
by inhibiting translation or promoting decay [16,17,18].
The study of PUF proteins in diverse model organisms revealed
widespread roles for these proteins in embryonic development,
stem-cell maintenance and neurogenesis [10,11]. In the fruit fly
Drosophila melanogaster, Pumilio (Pum) is required for proper
anterior/posterior patterning during early embryogenesis by
repression of the translation of hunchback mRNA [19]. Further-
more, Pum is also involved in the development and migration of
primordial germ cells [20,21,22], and it may be implicated in long-
term memory formation and neuronal excitability [23,24,25]. In
the nematode Caenorhabditis elegans, Fem-3 mRNA Binding Factors
1 and 2 (FBF-1, FBF-2) regulate the germline switch from
spermatogenesis to oogenesis by repressing fem-3 mRNA transla-
tion [26]. The six yeast Saccharomyces cerevisiae PUF proteins (Puf1p–
Puf6p) regulate aging, mating-type switching and mitochondrial
function [10,27,28].
Much less is known about the functions of PUF homologs in
vertebrates. Two paralogous PUF proteins exist in human, termed
Pumilio homolog 1 (PUM1) and Pumilio homolog 2 (PUM2).
PUM1 and PUM2 are often co-expressed in diverse tissues
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Based on few studies investigating PUM2 function, it is assumed
that mammalian PUFs have physiological roles analogous to the
non-vertebrate homologs: in germ cells, PUM2 interacts with
deleted in azoospermia (DAZ), DAZ-like (DAZL) proteins, and the
meiotic regulator BOULE (BOL), which are RBPs that function in
early germ line stem cells [29,31]. Moreover, mouse Pum2 mutants
have smaller testes, although fertility seems not to be affected [32].
Based on these results, a role for Pum2 in the maintenance of
germline stem cells was proposed [29,31]. PUM2 was recently
found to negatively regulate the expression of MAPK1 (mitogen-
activated protein kinase 1, ERK2) and MAPK14 (mitogen-
activated protein kinase 14) in human embryonic stem cells and
in the C. elegans germline. MAPK1 and MAPK14 are kinases
acting in the MAPK/ERK pathway that represses stem cell self-
renewal [33] and hence, these results sustain an ancestral role for
PUF proteins in maintenance and self-renewal of stem cells [10].
Recent evidence suggests additional roles of mammalian PUM2 in
neurons i.e. for maintaining synapse morphology and function
[30,34].
A major obstacle in the study of PUF proteins (and of RBPs in
general) is the lack of knowledge about the specific mRNA targets.
Systematic identification of the RNAs associated with RBPs in vivo
is therefore needed to identify the potential RNA targets that may
undergo regulation. In addition, identifying target RNAs of
conserved RBPs in diverse organisms should provide insight into
evolutionary aspects of post-transcriptional regulatory networks.
We have previously identified the mRNA targets for PUF proteins
in the yeast Saccharomyces cerevisiae and the fruit fly Drosophila
melanogaster, revealing association of PUFs with distinct subsets of
mRNAs encoding functionally or cytotopically related proteins
that are part of the same macromolecular complex, localize to the
same subcellular region or act in the same signal transduction
pathway [35,36]. For example, yeast Puf3p binds nearly
exclusively to nuclear encoded mRNAs for mitochondrial proteins,
whereas Drosophila Pum in ovaries of adult flies associates with
mRNAs encoding nuclear proteins involved in nucleotide
metabolism and transcriptional regulation, and many mRNAs
coding for proteins localized to organelle membranes. These
studies provided strong evidence for the presence of a highly
organized post-transcriptional regulatory system that coordinates
the fates of functionally related groups of mRNAs as ‘post-
transcriptional operons’ or RNA regulons [2,37,38]. Moreover,
the knowledge of RBP target RNAs initiated diverse follow-up
experiments unraveling new functions of these proteins
[25,28,39,40].
We have now undertaken a systematic analysis of the mRNAs
associated with the two human PUM proteins to provide a
framework for the study of their functional implications.
Surprisingly, our list of experimentally defined PUM targets
predicts extensive connections to the miRNA regulatory system,
providing a first indication that ‘cross-talk’ between translational
regulation through RBPs and miRNAs may be more frequent
than previously appreciated [41,42,43].
Results
Human PUM 1 and PUM 2 associate with hundreds of
mRNAs in HeLa S3 cancer cells
To identify mRNAs associated with human PUM proteins, we
used a modified Ribonucleoprotein-ImmunoPrecipitation Micro-
array (RIP-Chip) approach on HeLa S3 cancer cells that express
both PUM1 and PUM2 (Figure S1A) [44]. PUM ribonucleopro-
tein (RNP) complexes were captured from cell-free extracts with
specific antibodies coupled to either protein G (PUM1) or protein
A (PUM2) sepharose beads, and then eluted with SDS-EDTA
(Figure S1B). To control for non-specifically enriched RNAs, the
same procedure was performed with beads that were not coupled
with immunoprecipitating antibodies (mock samples). RNA was
isolated from extracts (input) and from the immunopurified (IPed)
samples, amplified, and labeled with Cy3 and Cy5 fluorescent
dyes, respectively. The labeled RNA probes from total RNA and
IPed RNA were mixed and competitively hybridized to human
cDNA microarrays that contained probes for ,26,000 transcripts.
In this assay, the ratio of the two RNA populations at a given array
element reflects the enrichment of the respective mRNA by the
PUM affinity purification [35,36].
To generate a list of mRNAs that were consistently enriched by
PUMs and hence represent likely targets, we compared association
of transcripts from PUM affinity isolations to the mock isolates by
unpaired two-class Significance Analysis of Microarrays (SAM)
and determined false discovery rates (FDRs) for each array
element [45]. 1766 transcripts representing 1424 ENSEMBL
annotated genes were consistently associated with PUM1 with
FDRs of less than 5%. (Figure 1A, Table S1, a complete list of
PUM1 mRNA targets is provided in Table S2). Likewise, we
identified 751 transcripts (575 ENSEMBL genes) that were
reproducibly associated with PUM2 with FDRs of less than 5%
(Figure 1B, Table S1, a complete list of PUM2 mRNA targets is
provided in Table S3). Strikingly, 507 (88%) of the PUM2 target
genes were also among the experimentally defined PUM1 targets,
indicating that the two human PUM paralogs have very similar
substrate specificities and possibly act redundantly on common
targets (Figure 1C). This finding correlates with the high amino
acid conservation among PUM paralogs (83% similarity) and their
respective RNA-binding domains (PUM-HD; 91% identity),
where all of the critical amino-acids that directly contact RNA
are fully conserved [13]. Furthermore, immunoblot analysis of
PUM1 and PUM2 RIP eluates with a-PUM2 and a-PUM1
antibodies, respectively, did not show co-immunoprecipitation of
the two paralogous proteins, thus excluding the possibility that the
target overlap was simply due to simultaneous protein pull-down
(Figure S1B).
In spite of the extensive overlap between the target sets of the
two proteins, 138 PUM2 associated transcripts (representing 68
ENSEMBL annotated genes) did not pass the threshold to be
selected as PUM1 target. Likewise, we identified over 1000
transcripts (representing 917 genes) that were only associated with
PUM1 but not with PUM2 (Tables S2, S3). However, we observed
substantial PUM2 protein degradation during the RIP procedure
(Figure S1, data not shown) and hence, may have lost associations
with a fraction of mRNA targets during the procedure, possibly
reducing the number of identified targets. Apart from this, false-
positives from unspecific antibody binding, or other PUM-
interacting proteins that pulled down additional mRNAs could
have contributed to differential mRNA associations. However,
since most transcripts bear a canonical PUF-binding motif (see
below), we believe that they represent true PUM targets.
Differential associations may be attributed to slightly different
substrate selectivity of the paralogous PUM proteins, possibly
defined by additional sequence or structural elements in the
vicinity of the PUF-binding site.
Human PUM proteins associate with functionally related
messages
To identify functional themes among the mRNAs associated
with PUM1 and PUM2, we searched for shared Protein ANalysis
THrough Evolutionary Relationships (PANTHER) [46] and Gene
Human PUM mRNA Targets
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mRNA targets with FDR,5% (Table 1, for a detailed list of
significant annotations see Table S4). PANTHER pathway
analysis of PUM1 targets revealed significant enrichment of
components that regulate angiogenesis (p,8610
27) or that
mediate inflammatory/immune responses (T and B cell activation,
p,5610
24 and p,10
22, respectively). We also found strong
enrichment of pathways important for cell-proliferation and stress
response such as the Ras (p,1610
26), the platelet-derived growth
factor (PDGF, p,3610
24) and epidermal growth factor (EGF,
p,10
22) signaling pathways. Although several components of
these pathways were also associated with PUM2, the respective
terms did not reach statistical significance. The analysis for PUM2
targets revealed only two terms with weak statistical significance:
the p53 pathway (p,10
22), which was also weakly enriched
among PUM1 targets (p,10
23), and several messages coding for
proteins related to Parkinson’s disease (p,2610
22) (Table 1,
Table S4).
We were intrigued by the finding that PUM targets often
encode proteins linked to angiogenesis - the process that promotes
the formation of new blood vessels - and to the Ras (rat sarcoma)
signaling pathway, which virtually affects every aspect of cell
biology [48,49]. We have therefore further mapped the interac-
tions of the encoded proteins (Figure 2). Thirty-seven PUM1
bound mRNAs are assigned to the term ‘angiogenesis’ by
PANTHER (Figure 2A). These include messages for diverse
tyrosine kinase receptors including fms-related tyrosine kinase 1
(FLT1), which is a receptor for vascular endothelial growth factor
A (VEGF A), a main inducer of angiogenesis. Even though VEGF
A was not selected as a PUM target (FDR.86%), the 39-UTR
binds to PUM in vitro and bears a canonical PUF-binding motif,
suggesting that PUM may regulate VEGF A expression (see
below). Furthermore, PUM also targets components that trans-
duce the intracellular signals downstream of these receptors and
that are, at least in part, related to angiogenesis. For instance, parts
of the wingless (Wnt) signaling pathway, including the three main
components of the ‘ß-catenin destruction complex’ [50], or
activators and effectors of Ras (Figure 2B) [49]. Finally, PUMs
also bind diverse messages that are final targets of these signaling
pathways, such as transcription factors that induce expression of
angiogenic modulators or regulate cell proliferation or survival
(Jun, STAT1, TCF4, TCF7L2). However, there is no apparent
preference for PUMs to act selectively on positive or negative
regulators of angiogenesis.
We finally searched for subcellular localization among PUM
targets revealing that PUM associated mRNAs preferentially
encode membrane-bound, cytoplasmic and nuclear proteins
(Table 1, Table S4). The latter compartment mainly relates to
transcription factors and their regulators, but also to RBPs. In this
regard, PUM2 mRNAs was highly associated with PUM1 and
PUM2 (FDR,0), suggesting the presence of negative feed-back
loops for self-regulation of PUM expression. In the cytoplasm,
PUM1 targets many messages coding for kinases, in particular
non-receptor serine/threonine protein kinases. Most of these
Figure 1. mRNAs specifically associated with human PUM proteins. Rows represent unique transcripts ordered according to increasing FDRs
determined by SAM analysis. Columns represent individual experiments. The colour code indicates the degree of enrichment (green-red log2 ratio
scale). (A) mRNAs associated with PUM1. Three experiments with PUM1 protein and three mock experiments both with dye-swap technical replicates
are shown. (B) mRNAs associated with PUM2. Four experiments with PUM2 protein and three mock experiments are shown. (C). Venn diagram
representing overlap between PUM1 and PUM2 targeted transcripts (right) and the corresponding genes (ENSEMBL, left).
doi:10.1371/journal.pone.0003164.g001
Human PUM mRNA Targets
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indicating the presence of additional factors that direct the binding
of functional groups of mRNAs to PUM proteins.
Conservation of functional groups but not of
homologous messages between yeast, fly and human
We have previously mapped the mRNAs associated with
Drosophila Pum in adult flies, and we wondered whether these
interactions may have been evolutionarily conserved [36]. We
noticed partial overlap of functional groupings made of proteins
encoded by PUF associated mRNAs. As seen for the human PUM
proteins, Drosophila Pum preferentially targets messages coding for
proteins located on membrane-bound organelle (p,10
27) and
nuclear proteins (p,10
25), including transcription factors, cyclins
and RNA-binding proteins [36]. We therefore asked whether this
consistency is directly reflected by association of the homologous
messages with the different PUF proteins. We retrieved human
homologs for the 1090 Drosophila Pum and for the 220 yeast Puf3p
mRNA targets. Notably, among yeast Puf proteins, Puf3p is most
related to human PUM and targets messages for nuclear encoded
mitochondrial proteins [35], a functional class that is not
particularly enriched among human PUMs. More than 40% of
the Drosophila and yeast Puf3p targets had an assigned human
homolog - however, only a small fraction of these messages were
also among our experimentally determined human PUM targets:
17% and ,7% of Drosophila Pum and a similar fraction of Puf3p
homologs were among PUM1 and PUM2 targets (Table S5).
Therefore, the conservation of functional themes among targets in
human and Drosophila is not directly reflected by the association
with homologous messages. Moreover, this indicates that the
suspected conservation of PUF’s physiological functions may not
necessarily imply the regulation of the same critical genes.
Table 1. Significantly shared PANTHER and GO annotations among PUM1 and PUM2 mRNA targets.
Category Term PUM1 p-value PUM2 p-value
Pathway (PANTHER) Angiogenesis 8610
27
Ras Pathway 1610
26
PDGF signaling pathway 3610
24
T cell activation 5610
24
p53 pathway 1610
23 9610
23
Interleukin signaling pathway 1610
22
EGF receptor signaling pathway 1610
22
B cell activation 1610
22
Parkinson’s disease 2610
22
Biological Process (PANTHER) Nucleoside, nucleotide and nucleic acid metabolism 1610
219 1610
26
Cell cycle 1610
214 9610
27
mRNA transcription 3610
213 5610
24
Protein phosphorylation 2610
28 3610
22
Intracellular protein traffic 3610
27 6610
23
Intracellular signaling cascade 6610
26 3610
22
Cell proliferation and differentiation 5610
25
Developmental processes 7610
25
Oncogenesis 1610
24
DNA repair 4610
24
MAPKKK cascade 1610
22
Molecular Function (PANTHER) Nucleic acid binding 6610
211 4610
26
Transcription factor 2610
210
Kinase 3610
29
Non-receptor serine/threonine protein kinase 3610
27
RNA-binding protein/mRNA binding 4610
24
Membrane traffic protein 1610
22
Component (GO) Intracellular membrane-bound organelle 7610
262 2610
225
Nucleus 6610
244 1610
214
Cytoplasm 2610
236 9610
212
Organelle lumen 4610
218 3610
27
Nuclear lumen 2610
216 8610
26
PANTHER: total 25,431 NCBI annotated genes.
GO: total 35,541 EBI annotated genes.
doi:10.1371/journal.pone.0003164.t001
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PLoS ONE | www.plosone.org 4 September 2008 | Volume 3 | Issue 9 | e3164Figure 2. PUM targets encode proteins acting in cancer related pathways. Components whose mRNAs are associated with PUM1 are
depicted in yellow, those bound by both PUM1 and PUM2 are shown in red. Messages that contain a PUF motif are shown with a thick black border.
(A) Regulators of angiogenesis. PUM associated messages code for the tyrosine kinase receptors fms-related tyrosine kinase 1 (FLT1), which is the
vascular endothelial growth factor receptor 1, fibroblast growth factor receptor 1 (FGFR1) and EPH receptor B4 (EPHB4) and its ligand ephrin-B1
(EFNB1). These receptors and their ligands can trigger signals that induce angiogenesis [73,74,75]. ARAF (v-raf murine sarcoma 3611 viral oncogene
homolog) and MAPK1 (mitogen-activated protein kinase 1) are part of the RAS/RAF/MAPK pathway that can activate ETS (E26 transformation specific
sequence) family transcription factors that promote angiogenesis [76]. Human PUM proteins commonly target messages of both canonical (Wnt/ß-
catenin) and non-canonical (Wnt/calcium signaling and planar cell polarity) pathways: WNT5A (wingless-type MMTV integration site family, member
5A) activates non-canonical Wnt signaling [77], which induces proliferation of endothelial cells in vitro. WNT5A is thought to promote the expression
of the angiogenic effectors MMP1 (matrix metallopeptidase 1), and TEK (endothelial TEK tyrosine kinase, TIE-2) [77]. PUM1 and PUM2 commonly
target components of the ‘‘ß-catenin destruction complex’’ consisting of the serine/threonine kinase GSK3A (glycogen synthase kinase 3 alpha),
which phosphorylates ß-catenin marking the protein for ubiquitylation and rapid degradation by the proteasome, the tumor suppressor APC
(adenomatous polyposis coli), and the scaffold protein AXIN1. PUM1 further associates with mRNAs coding for the co-factors TCF/LEF1 (transcription
factor/lymphoid enhancer-binding factor 1) that become activated when ß-catenin enters the nucleus. This includes TCF4 and TCF7L27 (transcription
factors 4 and 7-like 2), that stimulate the transcription of genes implicated in cell growth regulation [50]. (B) Activators and effectors of RAS [49,78].
PUM bound messages code for EGFR (epidermal growth factor receptor), adaptor proteins GRB2 (growth factor receptor-bound protein 2) and SHC1
(Src homology 2 domain containing transforming protein 1), which activate Ras proteins upon recruitment of the guanine nucleotide exchange factor
SOS (son of sevenless). RAS interacts specifically with ARAF, MAP3K1 (mitogen-activated protein kinase kinase kinase 1), PIK3CB (phoshoinositide-3-
kinase, catalytic, beta polypeptide) and TIAM2 (T-cell lymphoma invasion and metastasis 2), which can initiate cascades of protein-protein
interactions and further activate more specific signaling pathways. Components of the Raf/MEK/ERK and the MEKK/SEK/JNK pathways are covered by
PUM1 targets encoding mitogen-activated protein kinases MAPK1 and MAPKAPK5 (mitogen-activated protein kinase-activated protein kinase 5), and
RPS6AK3 (ribosomal protein S6 kinase, polypeptide 3). These pathways target the transcription factors JUN (jun oncogene), ATF2 (activating
Human PUM mRNA Targets
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PUMILIO mRNA targets
Characteristic sequence motifs have been previously found in
the 39-UTRs of the mRNA targets of different PUF-family
members [10,33,35,36]. Thus, we examined the sets of mRNAs
that associate with PUM1 and PUM2 for the presence of common
motifs using Multiple Expectation maximization for Motif
Elicitation (MEME) as an unbiased motif discovery tool [51].
We compiled one hundred available 39-UTR sequences among
the most highly enriched PUM1 and PUM2 mRNA targets, and
MEME analysis identified a 12-nt consensus sequence encom-
passing a highly conserved 8-nt core motif UGUA(AUC)AUA
(Figure 3A). The 8-nt consensus motif is highly related to the
Drosophila Pum and yeast Puf3p mRNA binding site [35,36],
indicating the conservation of the recognition element during
evolution despite the lack of conservation of the PUF targets
among the considered species. We further evaluated the
occurrence of this motif among PUM mRNA targets by searching
UTRs and coding sequences (CDSs) for the presence of the 8-nt
core motif UGUAnAUA using PatSearch [52]. 69% of the PUM1
mRNA targets (p,10
2100) and 74% of the PUM2 targets
(p,10
2100) contained the consensus motif in the 39-UTR, which
represents a striking enrichment compared to its genome-wide
occurrence in 39-UTRs (20% of all ENSEMBL annotated genes;
22% of all genes for which data could be obtained for microarray
cDNA probes). We also found the motif highly overrepresented in
the CDS of mRNA targets (13% of PUM1 and PUM2 mRNA
targets with p values of ,10
2100 and 10
215, respectively), but it is
almost absent in 59-UTRs (Table 2, for detailed statistics on motif
occurrences see Tables S6, S7). These results are consistent with
the observed enrichment of PUF-binding motifs in coding
sequences of mRNAs targeted by yeast PUF proteins [35].
Moreover, the functionality of PUF motifs in CDS has recently
been demonstrated for paralytic (para) mRNA, which codes for a
sodium channel expressed in neurons of Drosophila larvae [25].
We next analyzed the distribution of PUF consensus motifs.
Approximately 85% of PUM1 and PUM2 mRNAs targets bear
the motif exclusively in the 39-UTRs, 3–5% (PUM2 and PUM1,
respectively) solely in the CDS, and ,17% bear the motif in both
the CDS and 39-UTRs (Figure 3B). Most of the PUM bound
messages have only one PUF motif (Figure 3C). However, a
substantial fraction – one third of the PUM2 bound messages
(32%) - bears at least two consensus PUF-binding motifs in the 39-
UTRs. The distance between multiple motifs is similarly
distributed among the PUM1 and PUM2 mRNA targets ranging
up to 4000 nts with median distances of 324 nts and 230 nts for
PUM1 and PUM2 targets, respectively (Figure 3D). Nevertheless,
a large proportion of the double motifs are located within 200 nts
(94, 36% PUM1 and 58, 25% PUM2), and a ‘peak’ was found at a
distance of ,20 nts, indicating that the two motifs are preferen-
tially located in close proximity (Figure 3D, inlet). Such repetitive
occurrence of PUF binding sites may affect RNA regulation:
different sites could have different affinities for PUF binding
leading to dose-dependent or allosteric regulation. Such a mode of
regulation has been proposed for messages of C. elegans MAP
Kinase 1 (mpk-1) mRNA, which bears two distinct FBF binding
sites with five-fold different binding affinities [33].
We finally questioned whether the positions within and around
the PUF-binding motifs were evolutionarily conserved in mam-
mals [53]. We used as measure of evolutionary conservation the
phastCons score [54] representing the probability that a given
nucleotide is part of a block of conservation, given the genome
alignments of a number of placental mammals (human, chimpan-
zee, rhesus monkey, bush baby, treeshrew, rat, mouse, guinea pig,
rabbit, shrew, hedgehog, dog, cat, horse, cow, armadillo, elephant
and tenrec). In this way, we identified the PUF motifs in the
PUM1 and PUM2 IPed transcripts (targets) and in the expressed
transcripts that were not IPed (non-targets), and we used
transcript-to-genome alignments to determine the genomic
coordinates of the PUF motifs. For each nucleotide in the PUF
motif and each nucleotide up to 2400 nts upstream and to
+400 nts downstream of the motif, we extracted the phastCons
score. We then used the Wilcoxon test to determine whether the
positions in and around PUF sites from IPed transcripts were more
highly conserved than positions in and around non-IPed
transcripts. The profiles of the Wilcoxon test for PUM1 and
PUM2 sites, as represented by the logarithms of the p-values, are
shown in Figure 3E. Position of PUF motifs in PUM1 and PUM2
targets are more conserved than in non-targets (p-values are
smallest for positions within the PUM sites). Moreover, we found
that the PUF motifs in PUM1 and PUM2 targets reside in longer
(400 nucleotides) blocks of conservation compared to PUF motifs
in non-targets. Thus, the observed constraints on the positions of
PUF motifs in the PUM target mRNAs, but not in non-target
RNAs suggests that these motifs are indeed functionally conserved.
These findings further indicate that other factors may contribute
to or modulate the functionality of PUM binding sites, for example
recognition elements for cofactors like Nanos, which is known to
interact with Pumilio to mediate translational repression [55].
RNA pull-down experiments confirm PUM binding to
selected substrates
To evaluate some of our identified PUM mRNA substrates, we
performed RNA pull-down experiments using in vitro transcribed
biotinylated mRNAs added to extracts prepared from HeLa cells
expressing TAP-tagged PUM1-HD or PUM2-HD. We tested
biotinylated 39-UTR sequences of six potential targets that contain
the PUF motif: integrator complex subunit 2 (INTS2), defective in
cullin neddylation 1, domain containing 3 (DCUN1D3), delta-like
1 (Dll1), SDA1 domain containing 1 (SDAD1), VEGFA and
hepatocyte growth factor receptor (MET). INTS2, MET and
other members of the DCUN1 (DCUN1D1, DCUN1D4) and Dll
gene families (Dll3) were among our list of IPed PUM mRNAs
targets, whereas SDAD1 and VEGFA were not among the IPed
messages, though they bear a conserved PUF binding motif.
Moreover, SDAD1 was previously found to interact with PUM2
[56]. We also tested yeast cytochrome c oxidase (COX10), a known
target for the yeast PUF3 protein, which bears the 8-nt core
consensus motif [35], and a negative control RNA (Ribosomal
protein S26, RpS26) that does not bind to PUFs [36]. All of the
transcription factor 2) and STAT1 (signal transducer and activator of transcription), which commonly induce cell proliferation [49]. The PI3K-mediated
(PIK3CB) signal is further triggered by activation of protein kinase B (AKT1, v-akt murine thymoma viral homolog 1) and phosphorylates GSK3A. PUM1
also targets effectors downstream of TIAM such as the GTP-binding protein RAC1 (ras-related C3 botulinum toxin substrate 1) and the Ras homologs
gene family members B, F and J (RHOB, RHOF, RHOJ), which are all components of the TIAM/RAC/RHO signaling pathway implicated in the
reorganization of the actin cytoskeleton [79]. The RAC effector PAK2 (p21 protein- activated kinase 2) is involved in cell migration and invasion [80],
and EXOC2 (exocyst complex component 2) induces vescicle trafficking upon RAL (Ras-related) activation [49].
doi:10.1371/journal.pone.0003164.g002
Human PUM mRNA Targets
PLoS ONE | www.plosone.org 6 September 2008 | Volume 3 | Issue 9 | e3164Figure 3. Analysis of an RNA consensus sequence associated with human PUM proteins. (A) PUF consensus motif in 39-UTR sequences
associated with PUM1, PUM2, Drosophila Pum and yeast Puf3, Puf4 and Puf5 proteins [35,36]. Height of the letters indicates the probability of
appearing at the position in the motif. Nucleotides with less than 10% appearance were omitted. (B) Distribution of PUF consensus motifs. (C)
Number of PUF motifs in the 39-UTRs of PUM bound messages. (D) Distances between double PUF motifs present in 39-UTR. Represented bins are
50 nts (0–4000 nts distance) and 10 nts (0–200 nts distance). (E) Analysis of PUF motif conservation among PUM1 and PUM2 targets. The x-axis
shows the position (relative to the middle of the PUF motif), and the y-axis shows the logarithm (base 10) of the p-value from the Wilcoxon test
determining whether conservation scores come from the same distribution for PUM targets and non-targets. The vertical blue line is drawn at
position 0 corresponding to the PUF motif. The dashed black line is drawn at a p-value of 0.05, the continuous black line at a p-value of 0.01, and the
red line at a p-value of 10
25, which is the threshold for significance considering multiple testing.
doi:10.1371/journal.pone.0003164.g003
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PUM2-HD, whereas the RpS26 control 39-UTR sequence did not
(Figure 4A). Moreover, addition of a 10-nt competitor RNA
comprising the consensus sequence prevented binding to biotiny-
lated Dll1 RNA, but no such competition was seen with a control
RNA, in which the conserved UGU trinucleotide within the core
was mutated to ACA (Figure 4B, data not shown). Likewise,
mutation of this PUM binding site in a fragment of the MET RNA
also abolished binding (Figure 4B). Notably, probing of the same
immunoblots with PUM1 and PUM2 specific antibodies to detect
the full-length proteins gave analogous results (data not shown).
These results suggest that PUM1 and PUM2 have identical basal
substrate specificities, reminiscent of the largely overlapping set of
PUM1 and PUM2 mRNA targets identified by RIP-Chip. This
suggests that the presence of the computationally inferred core
motif is sufficient for association with human PUM proteins in vitro.
However, since SDAD1 and VEGFA were not among our IPed
mRNA targets, the in vitro binding activities may not always reflect
in vivo association, which may be controlled by additional factors.
The discrepancy may also be due to technical issues related to the
experimental procedure, or the computational analysis of the
microarray data.
The PUF motif is enriched around predicted miRNA
binding sites
Initial application of the Phylogibbs algorithm for motif finding
[57] to 39-UTR regions around high-confidence predicted
microRNA (miRNA) target sites [58] suggested that the PUF-
binding motif could be enriched in these regions, as shown in
Figure 5A (Zavolan, unpublished). However, this motif (UGUA-
nAUA) is A/U-rich, and high-confidence miRNA sites are known
to reside in A/U-rich regions [58,59]. Thus, we decided to test
directly whether the PUF-binding motif indeed occurs in the
vicinity of high-confidence miRNA sites at a higher frequency
than expected at a random distribution, particularly given its
nucleotide composition. We extracted from our miRNA target
predictions [58] the top 1000 target sites with the highest
probability of being under evolutionary selection, and an equal
number of target sites with the lowest probability of being under
evolutionary selection, by choosing for each miRNA having at
least one high-probability target site, an equal number of low-
probability sites. We then extracted 400 nucleotides upstream or
400 nucleotides downstream of the miRNA seed match (match to
the nucleotides 1–7, 2–8, or 1–8 of the miRNA), and counted how
many of the 1000 sequences contained the PUF consensus motif.
For the upstream regions, we found 132 positive sequences (with
high-probability miRNA sites) and 71 negative sequences (with
low-probability miRNA sites) containing the PUF motif, whereas
for the downstream regions, 159 positive sequences and 56
negative sequences contained the PUF motif (Table S8). This
indicates that the frequency of the PUF motif is significantly higher
in the environment of high-probability miRNA sites (p-values of
8.9610
26 for the upstream and 1.8610
213 for the downstream
regions in the chi-square test). To rule out the possibility that this
enrichment was simply due to the structure of the PUF motif, we
performed the same analysis for all the 16384 possible motifs of the
same structure as the PUF motif (i.e. first four bases defined, the
fifth any of A/C/G/U and then the next three bases defined).
Table S8 shows these results for all of the motifs for which the
frequency was higher in regions around high-probability sites
compared to regions around low-probability sites. As expected, we
found that the environment of high-probability miRNA target sites
is enriched in many A/U-rich elements. Strikingly, the PUF-
binding motif is the second most significantly enriched motif (out
of 6750 motifs) in the downstream regions of miRNA sites, and the
fortieth most enriched motif (out of 6906 motifs) in the upstream
regions. This test thus supports the hypothesis that the pumilio
proteins share targets with the miRNA pathway.
As we mentioned above, the PUF motif is A/U-rich. We therefore
wondered whether the enrichment that we observed was simply due
to spurious matches to the PUF consensus that occur in the A/U-rich
regions around high-confidence miRNA target sites. To test this, we
generated by sequence shuffling 100 randomized sets of sequences
with the same nucleotide composition as the regions around high-
probability and low-probability miRNA target sites, respectively. We
Table 2. Number of PUF consensus motifs found in human
PUMILIO targets (FDR,5%).
Search option Sequences Motifs (%) p-value
PUM1 39-UTR 1416 977 (69) ,10
2100
CDS 1418 187 (13) ,10
2100
59-UTR 1390 24 (2) 5610
22
PUM2 39-UTR 571 422 (74) ,10
2100
CDS 572 73 (13) 6610
216
59-UTR 558 11 (2) 7610
22
doi:10.1371/journal.pone.0003164.t002
Figure 4. Validation of human PUM mRNA targets. RNA-protein
complexes formed between biotinylated 39-UTRs and extracts of HeLa
S3 cells expressing PUM1-HD-TAP and PUM2-HD-TAP were purified on
streptavidin magnetic beads and monitored for the presence of TAP-
PUM-HD by immunoblot analysis with anti-PAP antibody. (A) Biotin-
labeled 39-UTR sequences for indicated genes (lanes 3 to 8) were
incubated with PUM1-HD-TAP and PUM2-HD-TAP extracts (lane 1).
Rps26 39-UTR was used as negative control probe RNA (lanes 8/9). The
supernatant after pull-down with INTS2 is shown in lane 2. (B)
Validation of the PUF-binding motif. Biotinylated RNA corresponding
to the Dll1 39-UTR was combined with PUM1-HD-TAP extract (lane 2)
and 100-fold excess of competitor RNA (R1; AUUGUAAAUA; lane 3) or
control RNA where the core motif is mutated (R2; AUACAAAAUA; lane
4). A fragment of MET 39-UTR bearing wild type (UGU) or mutant (ACA)
PUF binding sites is shown in lanes 5 and 6.
doi:10.1371/journal.pone.0003164.g004
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PUF motif and performed the chi-square test. For the downstream
regions, the lowest p-value that we observed in a randomized set was
10
24, much higher than1.8610
213 observedfortherealdataset.For
comparison, the lowest p-value that we observed in a randomized set
for the motif that was most enriched in the real data set
(TTTTNTAA, p=1.3 610
214)w a s1 . 4 610
210. For the upstream
regions the p- v a l u eo ft h er e a ld a t as e tw a so n l ym a r g i n a l l yl o w e r
compared to the lowest p-value we obtained for the randomized
variants (8.9610
26 compared to 5.1610
25). These results indicate
that the frequent occurrence of the PUF motif downstream of the
high-confidence target sites cannot be explained simply by the
nucleotide composition of these regions, and thus could suggest a
functionally-relevant localization of the PUF-binding motif down-
stream of the miRNA sites for the interplay between the two systems.
High-confidence miRNA binding sites are enriched in the
39-UTRs of experimentally determined PUM targets
We wondered whether our experimentally determined sets of
PUM targets provide evidence that miRNAs and PUMs share
target mRNAs. Thus, we first selected from our experimental data
sets PUM1 or PUM2 targets (IPed), as well as expressed transcripts
that were not PUM1 and PUM2 targets (non-IPed). We then
computed the density of high-probability miRNA sites (p$0.5
computed by the method of Gaidatzis [58] (http://www.mirz.
unibas.ch/ElMMo2) in the two data sets. The distribution of
densities for IPed and not IPed transcripts is shown in Figure 5B.
The p-value of the Wilcoxon test was ,2.2610
216 for both PUM1
and PUM2 targets, indicating that PUMs tends to target
transcripts that are enriched in high-probability miRNA sites,
and suggesting that there could be cross-talk between the two
systems. In fact, evidence for an interaction of a PUF protein with
the miRNA pathway already exists: it has been previously shown
that C. elegans puf-9 is required for the repression of the let-7
miRNA target HunchBack Like (hbl-1) [43]. We therefore selected
a set of candidates that appear most promising for follow-up
studies. These are 197 PUM1 and 77 PUM2 targets that contain a
high-probability miRNA site and a PUF site conserved among
human, rhesus, cow, dog and mouse that are located within 50
nucleotides of each other (Table S9).
Figure 5. miRNA binding sites are enriched among human PUM targets. (A) Example of a motif identified using the Phylogibbs motif finding
algorithm in the vicinity (400 nucleotides upstream) of high-confidence miR-30a target sites. The x-axis indicates the position of a nucleotide in the
inferred motif, and the y-axis gives the information score (bits) at that position. The height of each letter is proportional to the frequency of the
respective nucleotide at that particular position in the alignment of inferred sites. (B) Distribution of the density of high-confidence miRNA sites (sites
per nucleotide of 39-UTR) in the 39 UTRs of PUM targets (IPed, red) and non-targets (non-IPed, black).
doi:10.1371/journal.pone.0003164.g005
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We have systematically analyzed the mRNAs associated with
the two human Pumilio RNA-binding proteins, PUM1 and PUM2
in HeLa S3 cancer cells, using a method that combines the
recovery of endogenous RNP complexes and DNA microarray
analysis of the associated mRNAs [2,44,60,61,62]. We identified
more than one thousand PUM1 and hundreds of PUM2
associated mRNAs, providing the first comparative analysis of
mRNAs associated with paralogous PUF proteins in vertebrates.
Our data suggests that PUM proteins potentially regulate
approximately 15% of the cell’s transcriptome. A similar fraction
of the transcriptome was found to be associated with the five yeast
PUF proteins and the Drosophila homolog Pumilio, indicating that
PUF proteins generally coordinate large sets of mRNAs with
functional implications that may not be simply attributed to a few
specific mRNA targets.
The sets of human PUM1 and PUM2 associated mRNAs
strongly overlapped, suggesting that PUM1 and PUM2 have
similar substrate specificities (Figure 1). The presence of identical
PUF-binding elements among the PUM1 and PUM2 associated
mRNAs (Figure 3), and equal binding of PUM1 and PUM2 to a
set of synthetic RNAs in RNA pull-down experiments further
corroborated this notion (Figure 4). These results agree with recent
structural studies of PUM-HD in complex with RNA. The PUM-
HDs of mammalian PUM proteins are highly related (91% amino
acid identity) and all of the critical amino-acids that make direct
contact with the RNA are fully-conserved [11]. The human PUM
proteins are therefore different from the PUF proteins in S.
cerevisiae or C. elegans, where individual PUF family members have
altered substrate specificities and only marginally share common
sets of mRNAs [35,63]. However, despite this large overlap of
mRNA targets in HeLa cells, each PUM was also associated with a
distinct set of mRNAs indicating that additional factors may
further specify substrate selectivity in vivo.
Functionally relatedgroups ofmRNAs were often associated with
both PUM1 andPUM2(Table1,Figure2).However,some ofthem
were preferentially enriched with either PUM1 or PUM2. For
instance,angiogenesis-relatedproteinsweremainlyenrichedamong
PUM1 targets whereas the transcripts coding for proteins linked to
Parkinson’s disease were solely enriched among PUM2 targets.
Notably, the same functional attributes can often be found among
all genes with a conserved PUF motif in 39-UTRs [53], including
angiogenesis (p,10
213) and Parkinson’s disease (p.10
25) (for a list
of PANTHER and GO terms that are enriched among predicted
PUF targets see Table S10). However, some functional groups were
differentially enriched among experimentally determined and
predicted mRNA targets: for example, the Ras signaling pathway
was enriched among PUM1 targets, but not among the predicted
ones, whereas the Wnt signaling pathway is only significantly
overrepresented among the predicted targets (p,3610
28). More-
over, a fraction of the predicted targets encode proteins involved in
neurogenesis (p,2610
235) possibly relating to PUM functions in
neurons [23,24,25]. However, since we have analyzed PUM targets
in cancer cells, these neuron-specific mRNA targets were not
expected to be identified. In conclusion, these analyses revealed
PUM- and possibly cell/tissue-specific functional attributes among
the potentially regulated messages, and it will be a future challenge
to investigate the functional roles of PUM regulation on key targets.
During preparation of this manuscript, a ribonomic analysis has
been published where mRNAs associated with PUM1 were
identified and analyzed [61]. This study by Morris et al. applied
a very similar RIP-Chip approach as we did by using the same
PUM1 antibodies on HeLa S3 cells. Morris et al. defined 726
PUM1 mRNA targets (representing 11.1% of the 6,539 expressed
genes). 397 of these mRNA targets (55%) were also among our
experimentally identified PUM1 targets with a 5% FDR; and for
902 of our defined PUM1 targets that were represented on their
arrays, 756 (85%) were more enriched than the median IP
enrichment (t-scores) of all mRNAs. Furthermore, Morris et al. also
identified the core PUF motif in almost half of 39-UTRs of mRNA
targets. Therefore, our data is in broad general agreement with the
data from Morris et al. despite some significant differences in the
experimental set-up and microarray data analysis. For instance,
different number of replicate arrays were used (three by Morris et
al. vs. six in our study), different types of arrays and hybridization
conditions (separate vs. competitive hybridization, total IP-ed RNA
vs. amplified mRNA and oligo- vs. cDNA-arrays) and different
statistical analyses (Gaussian mixture modeling with log of odds
(LOD) scores vs. SAM). For instance, the larger number of
replicates used in our study, our RNA amplification strategy and
microarray analysis of more transcripts has probably lead to the
identification of almost twice the number of mRNA targets
compared to Morris et al. (1424 vs. 726) - most of them (.80%)
bearing a PUM motif in the 39-UTR or coding sequence.
Nevertheless, both studies found that PUM1 associated mRNAs
belong to a relatively small number of functional groups, mainly
genes coding for proteins that function in transcriptional
regulation and cell cycle/proliferation. These and our own results
therefore strongly support the ‘RNA operon/regulon model’,
which suggests the coordinate cis-/trans-regulation of multiple
mRNAs coding for proteins with related functions [37,38].
Interestingly, some functional groups have apparently been
conserved between human and Drosophila. For instance, in both
Drosophila and human, PUFs preferentially target messages for
nuclear proteins that encode transcription factors and membrane
associated proteins. However, it is intriguing that the conservation
of functional themes among targets in human and Drosophila is not
reflected by conservation of the particular homologous messages,
which is consistent with data obtained by Keene and his colleagues
[61]. This finding is intriguing in respect of the assumed
conservation of physiological function of PUM proteins for
germ-cell development and neurogenesis, suggesting that analo-
gous phenotypes may be accomplished by targeting related
mRNAs that are part of the same regulatory network. However,
we want to note that this comparative analysis of targets in flies
and human is hampered by the fact that PUM targets have been
analyzed in different experimental set-ups (whole flies versus
cultured cells) and therefore, the data is not directly comparable.
As seen in previous systematic analyses of mRNA targets of the
yeast and Drosophila Pumilio proteins [35,36], most of the human
PUM targets contain a characteristic PUF-binding motif in the 39-
UTR, and a significant number of targets bear the motif in the
CDS (Table 2). Moreover, almost half of the experimentally
determined targets have multiple PUF binding motifs (Figure 3C).
These findings raise the question about possible roles for the
position and multiplicity of PUF motif in transcripts. The different
binding sites may be used alternatively, or may bear different
affinities as observed for the C. elegans FBF-1 and FBF-2 target mpk-
1 [33]. PUM1 and PUM2 may therefore compete or synergisti-
cally act on common RNA substrates. Slightly different prefer-
ences for RNA-binding, but also in the expression levels of PUM
proteins may influence binding with alternative outcomes for the
fate of the mRNA. Finally, it is possible that other factors
contribute to or modulate the functionality of PUM binding sites.
Actually, our analysis shows that not only the PUF sites are
conserved among the PUM targets compared to the non-targets,
but also longer blocks upstream and downstream of the PUF
Human PUM mRNA Targets
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could represent recognition sites for cofactors like nanos [55].
Our work provides first evidence that the PUF motif is enriched
around predicted miRNA binding, offering the possibility for
functionally relevant localization of the PUF binding site
downstream the miRNA sites for the interplay between the two
systems. This hypothesis is further sustained by the finding that
high-confidence miRNA binding sites are significantly enriched in
the 39-UTRs of experimentally determined PUM1 and PUM2
targets. One example for interaction of PUF proteins with the
miRNA pathway has already been described in C. elegans, where
puf-9 is required for repression of hbl-1 by let-7 miRNA [43]. The
39-UTR of hbl-1 transcript contains PUF binding sites as well as
binding sites for the let-7 miRNA family suggesting that PUFs and
miRNAs cooperate to negatively regulate common targets [43].
On the other hand, it has also been observed that RBPs and
miRNAs may directly compete with each other. For instance, the
evolutionarily conserved RBP dead end homolog 1 (DND1)
relieves miRNA-specific repression of several messages by binding
to uridine-rich regions (URRs) which are located in close
proximity to miRNA binding sites in the 39-UTR, and thereby,
prohibits miRNAs from associating with their target sites [42].
Another example constitutes the AU-rich element (ARE) binding
protein Hu antigen R (ELAVL1) that counteracts hsa-miR-122
mediated repression of a cationic amino acid transporter
(SLC7A1, CAT-1) after stress treatment [41,64]. Additional
scenarios for how miRNAs could modulate RBP binding and
function in a dynamic manner have also been hypothesized [65].
For instance, miRNA binding could alter the structure of the
mRNA, which either ablates or provides binding sites for specific
RBPs and further alters the fate of the mRNA target. Therefore,
the functional interactions between PUF and miRNAs may well be
very mRNA target-specific because many additional factors and
combinatorial binding of RBPs and miRNAs may have an impact
on its final fait. It will be the topic of future investigation to
determine how PUF proteins interact with miRNAs on specific
model substrates.
Materials and Methods
Oligonucleotide primers
For a list of primers see Supporting Text S1.
Plasmid construction
Sequences coding for the C-terminal tandem affinity purifica-
tion (TAP)-tag were amplified with primers TAP1-NotIFw and
TAP2-XhoIRev from plasmid pBS1479 [66] by PCR, and cloned
into pcDNA3.1 (Invitrogen) via NotI and XhoI restriction sites,
generating plasmid pcDNA3.1-TAP. The sequences encoding the
C-terminal part of PUM1 (AF315592; amino acids 746–1186) and
PUM2 (AF31559; amino acids 624–1064) were PCR amplified
from cDNA clones IRAUp969B1150D (PUM1) and IR-
AUp969G0177D (PUM2) from the Deutsches Ressourcenzentrum
fu ¨r Genomforschung (RZPD) with primer pairs PUM1-HD-
EcoRVFw/PUM1-HD-NotIRev, and PUM2-HD-EcoRVFw/
PUM2-HD-NotIRev, and cloned via EcoRV and NotI sites into
pcDNA3.1-TAP, producing the plasmids pcDNA3.1-PUM1-HD-
TAP and pcDNA3.1-PUM2-HD-TAP, respectively.
Immunoblot analysis and antibodies
Protein samples were resolved on 8% SDS polyacrylamide gels
and transferred to nitrocellulose membranes (BioRad). Mem-
branes were blocked in phosphate buffered saline-0.1% Tween-20
(PBST) at 4uC overnight containing 5% low fat milk, probed with
the designated specific antibodies and horse radish peroxidase
(HRP)-coupled secondary antibodies, and developed with the
enhanced chemiluminescence detection kit (Amersham). The
following antibodies were used in this study (dilution indicated in
brackets): goat anti-PUMILIO 1 (1:25,000; Bethyl Laboratories,
#300-201A), rabbit anti-PUMILIO 2 (1:2,500; Bethyl Laborato-
ries, #A300-202A); mouse anti-ß-actin (1:3000; Sigma), HRP-
linked anti-mouse (1:2000; Sigma), HRP-linked anti-goat (1:5000;
Sigma); HRP-linked anti-rabbit (1:5000; Amersham). HRP-
coupled peroxidase anti-peroxidase antibody (PAP; 1:5000; Sigma)
was used to detect TAP-tagged proteins.
Cell culture and transfections
HeLa S3 cells were grown in Dulbecco’s Modified Eagle’s
Medium (DMEM) supplemented with 10% FBS (Gibco) and 1%
penicillin/streptomycin (Gibco). The cells were grown in dishes
(Falcon) in a humidified incubator at 37uC and 5% CO2. Two mg
of PUM-HD expression plasmids were transfected into one million
HeLa S3 cells with Superfect Transfection Reagent (Qiagen).
Stable cell lines expressing PUM2-HD-TAP were obtained upon
G418 antibiotic selection (400 mg/ml; Invitrogen).
Ribonucleoprotein-ImmunoPrecipitation (RIP)
RNA affinity isolations were performed essentially as described
[44]. HeLa S3 cells were grown in 15 cm dishes (Falcon) until 90%
confluency, washed in PBS and collected by centrifugation at
3,000 g and 4uC for 5 min. Cells were resuspended in an equal
volume of polysome lysis buffer (10 mM HEPES-KOH [pH 7.0],
100 mM KCl, 5 mM MgCl2, 25 mM EDTA, 0.5% IGEPAL,
2 mM dithiothreitol [DTT], 0.2 mg/ml Heparin, 50 U/ml
RNase OUT
TM [Invitrogen], 50 U/ml Superase IN
TM [Ambion],
16 complete protease inhibitor tablet [Roche]) and lysed by
repeated pipetting up and down. The suspension was centrifuged
three times at 14,000 g at 4uC for 10 min and aliquots were in
liquid nitrogen and stored at 280uC until use. Protein concen-
tration was determined by the Bradford method (Bio-Rad protein
assay, BioRad) with bovine serum albumin (BSA) as reference
standard.
50 ml protein G or protein A sepharose beads (Amersham) were
equilibrated in NT2 buffer (50 mM Tris-HCl [pH 7.5], 150 mM
NaCl, 1 mM MgCl2, 0.05% IGEPAL) supplemented with 5%
BSA (Equitech Bio), 0.02% sodium azide and 0.02 mg/ml
heparin. 20 mg of goat anti-PUM1 and 50 mg of rabbit anti-
PUM2 antibodies were then coupled to the blocked protein G and
protein A beads, respectively, which were further incubated on a
rotator for 12 hours at 4uC. No antibodies were added in mock
control experiments. The beads were subsequently washed three
times in NT2 buffer and resuspended in 5–10 ml NT2 buffer
supplemented with 30 mM EDTA (pH 8.0), 1 mM DTT, 50 U/
ml RNase OUT
TM and 50 U/ml Superase IN
TM (to decrease
unspecific binding to the beads, NT2 buffer corresponding to ten
volumes of extract was used). HeLa cell extract (20 mg protein)
was added to the antibody-coupled or mock beads, which were
then mixed on a rotator for 6 hours at 4uC. The beads were then
thoroughly washed four times in ice-cold NT2 buffer and RNP
complexes were eluted twice with 500 ml SDS-EDTA (50 mM
Tris [pH 8.0], 100 mM NaCl, 10 mM EDTA, 1% SDS) for
10 min at 65uC.
RNA isolation, amplification and fluorescent labeling
Total RNA was isolated from cell extracts and immunopurified
samples with the mirVana
TM PARIS
TM kit (Ambion). RNA was
quantified with a NanoDrop device (Witeg AG). Poly-adenylated
RNAs were amplified in the presence of aminoallyl-UTP with
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purpose, 500 ng total RNA from extracts and half (50–100 ng)
of the immunopurified RNAs were used for amplification. 8 mgo f
the amplified RNAs (aaRNA) were fluorescently labeled with
NHS-monoester Cy3 and Cy5 dyes (GE HealthSciences), except
for mock RNA samples, where an aaRNA amount proportional to
the yield obtained from corresponding PUM affinity isolates was
used. For PUM1 RIPs, we performed three biological replicates
with technical (dye swap) replicates (total six arrays). For PUM2
RIPs, we performed four biological replicates but omitted the dye
swaps due to the lower aaRNA obtained after amplification
(,10 mg aaRNA from PUM2 RIPs, ,40 mg aaRNA from PUM1
RIPs, ,9 mg aaRNA from mock RIPs). The Cy3- and Cy5-
labeled aaRNA samples were mixed and hybridized to human
cDNA microarrays.
Microarray analysis and data selection
Detailed methods for microarray experiments are available at
http://cmgm.stanford.edu/pbrown/protocols/index.html. cDNA
microarrays were produced by the Stanford Functional Genomic
Facility and contained 43,197 human probes representing 26,524
Unigene cluster IDs (12,466 ENSEMBL annotated genes) spotted
on Corning Ultra GAPS slides. Spotted cDNAs were cross-linked
with 65 mJ of UV irradiation on slides, which were then post-
processed for 1 hour at 42uC in pre-hybridization solution (56
SSC, 0.1% SDS, 0.1 mg/ml BSA), washed twice in 400 ml of
0.16SSC for 5 min, dunked in 400 ml ultrapure water for 30 sec,
and dried by centrifugation at 550 rpm for 5 min. Slides were used
the same day.
Cy3- and Cy5-labeled aaRNA probes were mixed and applied
to arrays in hybridization solution (36SSC, 20 mg poly(A) RNA
[Invitrogen], 20 mg yeast tRNA [Invitrogen], 20 mg Human Cot-1
DNA [Invitrogen], 20 mM HEPES [pH 7.0] and 0.3% SDS) for
18 h at 65uC. The arrays were then washed sequentially in 400 ml
of 26 SSC with 0.1% SDS, 16 SSC, and 0.26 SSC. The first
wash was performed for 5 min at 65uC, the subsequent washes
were performed for 5 min at RT. The arrays were dried by
centrifugation and immediately scanned with an AxonScanner
4200A (Molecular Devices). Data were collected using GENEPIX
5.1 (Molecular Devices). Arrays were normalized computationally
by the Stanford Microarray Database (SMD) [67]. The data were
filtered for signal over background of greater than 1.5 in the
channel measuring aaRNA from extract, and only features that
met these criteria in .50% of the arrays were included for further
analysis. Log2 median ratios were retrieved and exported into
Microsoft Excel.
To identify transcripts that were specifically enriched by
association with PUM1 and PUM2, we performed two class
Significance Analysis of Microarrays (SAM) on median centered
arrays [45]. Comparing six arrays representing PUM1 affinity
isolations (three independent experiments, each with a dye-swap
replicate) with six arrays representing mock isolates (three
independent experiments with dye swaps) identified 1674 tran-
scripts representing 1266 annotated genes with FDRs,1% and
2196 transcript (1755 annotated genes) with FDRs,5% (Table S1;
a list of PUM1 mRNA targets is shown in Table S2). Likewise,
comparing four arrays representing independent PUM2 affinity
isolations with three mock control arrays identified 400 transcripts
(307 annotated genes) with FDR,1%, and 889 transcripts (751
genes)withFDRs,5%(Table S1;a list of PUM2 targetsis shown in
Table S3). ENSEMBL gene identifiers (ENSG accession numbers)
and Reference Sequence mRNA identifiers (RefSeq; NM) were
retrieved from the Clone IDs (IMAGE numbers) represented on the
arrays using the CLONE|GENE ID converter (http://idconverter.
bioinfo.cnio.es/) [68]. Replicate probes representing the same
transcript were collapsed to ENSEMBL or RefSeq annotated
transcripts (=unique transcripts), whichwerethen mapped to genes
based on ENSG accession numbers (=annotated genes). All
microarray data is available at the Stanford Microarray Database
(SMD) or at the Gene Expression Omnibus at www.ncbi.nlm.nih.
gov/geo (GSE12357).
To compare our PUM1 mRNA targets with the ones defined by
Morris et al. [61], we retrieved the ENSG and RefSeq accession
numbers of the Morris et al. study from GEO (accession No. GSE
11301, platform GPL5770) and from the Supplemental Material
published on the journal’s web site.
Synthesis of biotinylated RNAs and pull-down
experiments
DNA templates for biotin-RNA synthesis were prepared by
PCR from 200 ng of HeLa S3 genomic DNA with 59-
oligonucleotides bearing a T7 RNA polymerase promoter
sequence, except for MET where complementary pairs of
oligonucleotides comprising nts 1950–2006 of MET were
annealed and cloned into psiCheck-2 (Promega). The following
oligonucleotide pairs were used to amplify the indicated regions
(specified by nucleotide positions) of 39-UTRs: INTS2-T7Fw and
INTS2-Rev for nucleotides (nts) 1800–2144 of INTS2,
DCUN1D3-T7Fw and DCUN1D3-Rev for nts 965–1474 of
DCUN1D3, Dll1-T7Fw and Dll1-Rev for nts 120–587 of Dll1,
SDAD1-T7Fw and SDAD1-Rev for nts 112–529 of SDAD1,
VEGFA-T7Fw and VEGFA-Rev for nts 925–1485 of VEGF-A.
The ORF plus 500 nts downstream of the yeast COX10 gene was
amplified with primers COX10-T7Fw and COX10-Cnot from S.
cerevisiae genomic DNA. The Rps26 control probe was prepared as
described [36]. Biotinylated RNAs were produced with T7-RNA
polymerase with biotin RNA labeling mixture (Roche) as
described [36].
Biotin RNA pull-down experiments were performed essentially
as described [36]. Extracts were prepared by mechanical
disruption with a Tissue Lyser (Qiagen; 66 30 sec, 30 Hz, 4uC)
from HeLa S3 cells that were either transiently transfected with
pcDNA3.1-PUM1-HD-TAP and collected after 24 hours, or that
stably expressed PUM2-HD-TAP. 130 mg (protein content) of
extract was incubated with 2 pmol of biotinylated RNAs, and
streptavidin captured RNA-protein complexes were resolved on a
10% SDS polyacrylamid gel. Proteins were visualized with PAP
antibody or specific anti-PUM antibodies.
Web-based database searches
Protein Analysis THrough Evolutionary Relationships (PAN-
THER) analysis was performed with PUM1 and PUM2 mRNA
targets (unique transcripts with 5% FDR) at http://www.
pantherdb.org/ [46]. Gene Ontology (GO) searches were per-
formed with the Generic Gene Ontology Term Finder (http://go.
princeton.edu/cgi-bin/GOTermFinder) [47]. For comparative
analysis of mRNA targets, ENSG IDs for predicted human
orthologs of Drosophila Pum and S. cerevisiae Puf3p targets [35,36]
were retrieved with Biomart (http://www.biomart.org/) [69].
Motif searches
39-UTR, 59-UTR and coding sequences were retrieved from
ENSEMBL (via ENSG IDs; Ensembl Release 48/1st December
2007) or GenBank (via RefSeq; release 164/February 2008)
[70,71]. Motif searches were performed with MEME (http://
meme.sdsc.edu/meme/meme.html) [51] on the first 100 39-UTR
sequences available corresponding to the 125 and 135 highest
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targets, respectively, with the following settings: searching the
sense strand, one motif per sequence and 6 to 10 nucleotides
expected motif length. The 39-UTR, 59-UTR and coding
sequences of PUM1 and PUM2 targets (FDR,5%) were searched
for PUF motifs (TGTAnATA) with PatSearch (http://www.ba.itb.
cnr.it/BIG/PatSearch/) [52]
For the conservation analysis of PUF motifs in PUM1 and
PUM2 targets and non-targets, the genomic location of PUF
motifs found in PUM1 and PUM2 targets (IPed transcripts) and
non-targets (expressed but not IPed transcripts) was inferred by
aligning the mRNAs to the hg18 assembly of the human genome
using the Spa algorithm [72], and the genomic coordinates of the
PUF motif were identified based on the coordinates in the mRNA
and the mRNA-to-genome alignments. The phastCons conserva-
tion scores for each nucleotide within 8 nucleotides-long regions
centered on the middle of the PUF motifs were extracted from the
UCSC site (http://hgdownload.cse.ucsc.edu/goldenPath/hg18/
database/phastCons17way.txt.gz) [54]. For each position around
the PUF motif we then constructed two vectors: one that
contained the conservation scores for that particular position
around PUF motifs in IPed transcripts, and the other containing
the conservation scores for that position around PUF motifs in
transcripts that were expressed but not IPed. Finally, we applied
the Wilcoxon test to the two vectors of conservation scores and
reported the position-wise profile of the logarithm of the p-value.
Extraction of miRNA target sites
From http://www.mirz.unibas.ch/ElMMo2 we extracted
miRNA target predictions generated based on the algorithm
previously described [58]. We extracted as high-confidence target
sites the top 1000 sites in the order of their posterior probability of
being under functional selection. An equal number of low-
confidence target sites was extracted by traversing the list of
predicted sites for each miRNA from the sites with lowest
probability to those with the highest probability, and selecting, for
each miRNA a number of low-probability sites equal to the
number of high-probability sites.
Motif searches with the Phylogibbs algorithm
To identify binding sites for protein cofactors of the miRNA
pathway, we applied the Phylogibbs algorithm [57] to the 400
nucleotide upstream and downstream regions of the high-
confidence sites of three miRNAs, which had a few hundred
high-confidence predicted targets (miR-30a – 210 upstream/208
downstream regions, miR-19 – 126 upstream/154 downstream
regions and miR-137 – 153 upstream/131 downstream regions).
The 39-UTRs of the predicted miRNA targets were mapped to the
hg18 assembly of the human genome using the Spa algorithm for
mRNA-to-genome mapping [72]. The genomic locations of the
miRNA target sites were identified based on the location of the
target sites in the 39-UTRs and the alignments of 39-UTRs to
genome. The genomic coordinates of the predicted sites were then
used to extract alignments that covered 400 nucleotides upstream
or downstream of the miRNA match in the following species:
mouse - mm8 assembly, rhesus monkey - rheMac2 assembly, dog -
canFam2 assembly, cow - bosTau2 assembly and horse - equCab1
assembly. The pair-wise genome alignments were obtained from
the genome browser web site of the University of California of
Santa Cruz (http://hgdownload.cse.ucsc.edu/goldenPath/hg18/
vsX, where X is the corresponding assembly as given above). The
orthologous regions were realigned using the T-coffee algorithm,
and then submitted to Phylogibbs. Without trying to perform an
exhaustive study, we used the following parameters: motif length
(m)=10, number of different motifs to infer (z)=2, expected
number of sites in a given set of sequences (y)=120, order of the
Markov model for background probabilities (N)=3.
Computation of the density of high-confidence miRNA
targets in the 39-UTRs of PUM1 and PUM2 targets and
non-targets
We intersected the set of mRNAs that had at least one high-
confidence (p$0.5) predicted miRNA target site in their 39-UTRs
with the sets of mRNAs that were IPed, or expressed but not IPed
in the PUM1 and PUM2 experiments. Then, for each mRNA, we
computed the density of high-confidence targets sites per 39-UTR
nucleotide by dividing the number of high-confidence sites in the
39-UTR by the total length of the 39-UTR.
Supporting Information
Text S1 Oligonucleotide primer sequences.
Found at: doi:10.1371/journal.pone.0003164.s001 (0.03 MB
DOC)
Figure S1 Immunoblot analysis of human PUM proteins in
HeLa S3 cells. (A) Expression of endogenous human PUM
proteins in HeLa S3 cells. Lane 1: Immunoblot analysis of PUM1
(127 kDa) probed with anti-PUM1 antibody (25 mg cell extract);
lane 2: Immunoblot analysis of PUM2 (114 kDa) probed with
anti-PUM2 antibody (50 mg cell extract). (B) Immunoblot analysis
following immunoprecipitation of PUM1 and PUM2 with anti-
PUM1 and anti-PUM2 antibodies. Lanes 1–4: PUM affinity
isolations; lanes 5–8: mock control isolations. Lanes 1, 5: cell
extract; lanes 2, 6: supernatant after incubation of extracts with
antibody-coupled protein G or protein A sepharose beads; lanes 3,
7: RNP eluates after treatment of beads with SDS-EDTA; lanes 4,
8: RNP eluates probed with the alternate PUM antibody. 25 mg
(PUM1) or 50 mg (PUM2) of extracts and supernatants, 5% of
captured beads and 1% of eluates were loaded.
Found at: doi:10.1371/journal.pone.0003164.s002 (3.61 MB TIF)
Table S1 mRNA specifically associated with PUM1 and PUM2.
Columns indicate the following (from left to right): total number of
transcripts (including replicates); total number of unique tran-
scripts; total number of transcripts with ENSEMBL gene IDs; all
listed according to FDRs determined by SAM.
Found at: doi:10.1371/journal.pone.0003164.s003 (0.02 MB
XLS)
Table S2 List of PUM1 target mRNAs in HeLa S3 cells.
Columns indicate the following (from left to right): Clone_ID
(IMAGE); gene name; gene description; average log2 ratio in
PUM1 affinity isolations; average log2 ratio in mock affinity
isolations; SAM score; FDR; Ensembl_Gene_ID; Ensembl_Gene
(+); RefseqRNA; EntrezGene; GenBank accession number; PUM2
target (+); PUM2 affinity isolation FDR; 39-UTR information
available (+); 39-UTR information available from ENSEMBL,
ENSG (+); PUF motif within 39-UTR (+); PUF motif within 39-
UTR from ENSG sequence (+); number of motifs within 39-UTR;
CDS information available (+); CDS information available from
ENSEMBL, ENSG (+); PUF motif within CDS (+); PUF motif
within CDS from ENSG sequence (+); number of motifs within
CDS; 59-UTR information available (+); 59-UTR information
available from ENSEMBL, ENSG (+); PUF motif within 59-UTR
(+); PUF motif within 59-UTR from ENSG sequence (+); number
of motifs within 59-UTR; miRNA binding site close (within 50 nts)
to 39-UTR PUF motif (+); distance between PUF and miRNA sites
(nts).
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XLS)
Table S3 List of PUM2 target mRNAs in HeLa S3 cells.
Columns indicate the following (from left to right): Clone_ID
(IMAGE); gene name; gene description; average log2 ratio PUM2
affinity isolations; average log2 ratio mock affinity isolations; SAM
score; FDR; Ensembl_Gene_ID; Ensembl_Gene (+); RefseqRNA;
EntrezGene; GenBank accession number; PUM1 target (+);
PUM1 affinity isolation FDR; 39-UTR information available (+);
39-UTR information available from ENSEMBL, ENSG (+); PUF
motif within 39-UTR (+); PUF motif within 39-UTR from ENSG
sequence (+); number of motifs within 39-UTR; CDS information
available (+); CDS information available from ENSEMBL, ENSG
(+); PUF motif within CDS (+); PUF motif within CDS from
ENSG sequence (+); number of motifs within CDS; 59-UTR
information available (+); 59-UTR information available from
ENSEMBL, ENSG (+); PUF motif within 59-UTR (+); number of
motifs within 59-UTR; PUF motif within 59-UTR from ENSG
sequence (+); miRNA binding site close (within 50 nts) to 39-UTR
PUF motif (+); distance between PUF and miRNA sites (nts).
Found at: doi:10.1371/journal.pone.0003164.s005 (0.32 MB
XLS)
Table S4 Significantly shared PANTHER and GO annotations
among PUM1 and PUM2 mRNA targets. (A) Significantly shared
PANTHER annotations among PUM1 mRNA targets. (B)
Significantly shared PANTHER annotations among PUM2
mRNA targets (C) Significantly shared GO annotations among
PUM1 targets (D) Significantly shared GO annotations among
PUM2 targets.
Found at: doi:10.1371/journal.pone.0003164.s006 (0.06 MB
XLS)
Table S5 Conservation between yeast, Drosophila and human
PUM targets. (A, B) Homologous messages conserved among
yeast, Drosophila and human pumilio targets. (C) Significantly
shared PANTHER annotations among 85 conserved PUM1 and
Drosophila Pumilio mRNA targets.
Found at: doi:10.1371/journal.pone.0003164.s007 (0.03 MB
XLS)
Table S6 Statistics of PUF motif among PUM1 targets. (A) 39-
UTRs. (B) CDS. (C) 59-UTR. Columns indicate the following
(from left to right): search option; number of ENSEMBL genes;
number of sequences retrieved from ENSEMBL; number of motifs
(number of motifs from ENSEMBL-retrieved sequences); p-value.
Found at: doi:10.1371/journal.pone.0003164.s008 (0.03 MB
XLS)
Table S7 Statistics of PUF motif among PUM2 targets. (A) 39-
UTRs. (B) CDS. (C) 59-UTR. Columns indicate the following
(from left to right): search option; number of ENSEMBL genes;
number of sequences retrieve from ENSEMBL; number of motifs
(number of motifs from ENSEMBL-retrieved sequences); p-value.
Found at: doi:10.1371/journal.pone.0003164.s009 (0.03 MB
XLS)
Table S8 Motifs enriched in the surrounding of miRNA binding
sites. Columns indicate the following: motif; number of positive
sequences; number of negative sequences; p-value. (A) Motifs
enriched downstream of miRNA binding sites. (B) Motifs enriched
upstream of miRNA binding sites.
Found at: doi:10.1371/journal.pone.0003164.s010 (1.22 MB
XLS)
Table S9 List of PUM targets with conserved PUF and miRNA
binding sites. Columns indicate the following: (A) Targets with
PUF and miRNA conserved double sites among the species
indicated in C (Homo sapiens, hg; Rhesus macaque, rheMac; Bos
Taurus, bosTau; Canis familiaris, camFam; Mus musculus, mm).
For each target, the first rows of C and D indicate the position of
PUF binding sites (start-end); the first rows of F and G indicate the
position of the miRNA binding sites (start-end) specified in E. H
indicates the probability that the miRNA binding site is under
selection; column I indicates the distance between PUM and
miRNA binding sites.
Found at: doi:10.1371/journal.pone.0003164.s011 (0.25 MB
XLS)
Table S10 Significantly shared PANTHER and GO annota-
tions among predicted human PUM targets. (A) Significantly
shared PANTHER annotations among predicted human PUM
targets. (B) Significantly shared GO annotations among predicted
human PUM targets.
Found at: doi:10.1371/journal.pone.0003164.s012 (0.05 MB
XLS)
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